Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer DiseaseStephen Salloway, Karen Smirnakis, Spyros Chalkias et al.|JAMA Neurology|2021Cited by 590